Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Additionally we are shipping Ubiquitin-Like Modifier Activating Enzyme 7 Antibodies (88) and Ubiquitin-Like Modifier Activating Enzyme 7 Kits (5) and many more products for this protein.
Showing 7 out of 8 products:
Inhibitor-sensitive tyrosine kinase (show TYRO3 Proteins) controls the population heterogeneity of basal STAT1 (show STAT1 Proteins) activity in Ube1l deficient fibroblasts.
Bone marrow transplantation experiment revealed a 50% reduction in repopulation potential of Ube1L-deficient cells at 3weeks posttransplantation, but no differences at 6 and 12weeks.
UBE1L and protein ISGylation are not critical for IFN-alpha (show IFNA Proteins)/beta signaling via JAK (show JAK3 Proteins)/STAT (show STAT1 Proteins) activation.
Ube1l is not a tumor suppressor gene in K-ras(LA2) lung cancer mouse model.
Both UbE1L(-/-) and ISG15 (show ISG15 Proteins)(-/-) mice display increased susceptibility to influenza B virus infection, including non-mouse-adapted strains.
The importance of UbE1L was confirmed by demonstrating that mice lacking this ISG15 (show ISG15 Proteins) E1 enzyme (show ENOPH1 Proteins) were highly susceptible to Sindbis virus infection.
ISG15 (show ISG15 Proteins), UBE1l and UBCH8 (show UBE2E2 Proteins) genes are significantly upregulated in the artificially inseminated pregnant cows.
the cellular effects of progerin expression in Hutchinson-Gilford progeria syndrome are transduced, at least in part, through reduced function of the Ran GTPase (show RAN Proteins) and E2 SUMOylation pathways.
UBE1L is a retinoid target that triggers PML (show PML Proteins)/RARalpha (show RARA Proteins) degradation and apoptosis in acute promyelocytic leukemia (show PML Proteins)
RA treatment of APL (show FASL Proteins) and other RA-responsive leukemic cells induced expression of UBE1L and ISG15 (show ISG15 Proteins) as well as intracellular ISG15 (show ISG15 Proteins) conjugates. A physical association was found between UBE1L and ISG15 (show ISG15 Proteins) in vivo.
Ube1L was required for transfer of ISG15 (show ISG15 Proteins) to UbcH8 (show UBE2E2 Proteins) and for binding of Ube1L to UbcH8 (show UBE2E2 Proteins)
UBE1L-ISG15 (show ISG15 Proteins) preferentially inhibits cyclin D1 (show CCND1 Proteins) in lung cancer
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E1 ubiquitin-activating enzyme family. The encoded enzyme is a retinoid target that triggers promyelocytic leukemia (PML)/retinoic acid receptor alpha (RARalpha) degradation and apoptosis in acute promyelocytic leukemia, where it is involved in the conjugation of the ubiquitin-like interferon-stimulated gene 15 protein.
ubiquitin-like modifier-activating enzyme 7
, ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivity complementing)
, ubiquitin-activating enzyme E1-like 2
, ubiquitin-activating enzyme E1-like
, ubiquitin-like modifier activating enzyme 7
, ubiquitin-like modifier-activating enzyme 7-like
, ubiquitin-conjugating enzyme E2R 2
, ubiquitin conjugating enzyme E2
, UBA1, ubiquitin-activating enzyme E1 homolog B
, UBA7, ubiquitin-activating enzyme E1
, ubiquitin-activating enzyme 7
, ubiquitin-activating enzyme E1 homolog
, ubiquitin-activating enzyme E1-related protein
, ubiquitin-activating enzyme-2